Preclinical Study

The preclinical study team of Bostal's strategically is dedicated to providing customized preclinical trial solutions. With strong expertise in preclinical pharmacology and pharmacodynamics, pharmacokinetics, toxicokinetics and safety evaluation, and extensive experience accumulated in research, the team can provide high quality preclinical data for your drug development or preclinical studies as well as valuable guidance for subsequent clinical study design.

Service Capability

The preclinical study team of Bostal's strategically has built a non-clinical drug evaluation research platform with 9 GLP certifications from NMPA and full accreditation of AAALAC, the preclinical data generated meet the requirements of dual submission in China and the United States; the platform has well-established GLP management system and is equipped with advanced experimental equipment and facilities which can provide high quality of non-clinical services for institutions and enterprises, such as drug safety evaluation, preclinical pharmacokinetic and toxicokinetics research, pharmacology and pharmacodynamics, new drug screening, new drug development, animal model preparation and research for human diseases, animal medical inspection and testing, IND or NDA services, etc,; the platform is particularly outstanding in the evaluation and research technology system of ophthalmic drugs, COVID-19 vaccine and anti-infective drugs, cell and gene therapy drugs, pediatric drugs, and dermatological preparations.

Service Contents

We provide professional preclinical study services, including:

◆Drug safety evaluation (GLP)

◆PD evaluation for new drugs

◆Non-clinical pharmacokinetics study

◆Animal medical inspection and testing

◆IND or NDA services